MC1232A1 - Nouveaux derives de 4-amino-5-alkylsulfonyl orthoanisamides,leurs procedes de preparation et leur application comme agents psychotropes - Google Patents

Nouveaux derives de 4-amino-5-alkylsulfonyl orthoanisamides,leurs procedes de preparation et leur application comme agents psychotropes

Info

Publication number
MC1232A1
MC1232A1 MC791357A MC1357A MC1232A1 MC 1232 A1 MC1232 A1 MC 1232A1 MC 791357 A MC791357 A MC 791357A MC 1357 A MC1357 A MC 1357A MC 1232 A1 MC1232 A1 MC 1232A1
Authority
MC
Monaco
Prior art keywords
amino
methoxy
ethyl
methyl
benzamide
Prior art date
Application number
MC791357A
Other languages
English (en)
French (fr)
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of MC1232A1 publication Critical patent/MC1232A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MC791357A 1978-01-20 1979-01-16 Nouveaux derives de 4-amino-5-alkylsulfonyl orthoanisamides,leurs procedes de preparation et leur application comme agents psychotropes MC1232A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (1)

Publication Number Publication Date
MC1232A1 true MC1232A1 (fr) 1979-10-26

Family

ID=9203689

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791357A MC1232A1 (fr) 1978-01-20 1979-01-16 Nouveaux derives de 4-amino-5-alkylsulfonyl orthoanisamides,leurs procedes de preparation et leur application comme agents psychotropes

Country Status (42)

Country Link
US (2) US4294828A (enExample)
JP (1) JPS6049192B2 (enExample)
AR (2) AR221354A1 (enExample)
AT (1) AT377977B (enExample)
AU (1) AU528561B2 (enExample)
BE (1) BE872585A (enExample)
BG (2) BG31497A3 (enExample)
CA (1) CA1101430A (enExample)
CH (1) CH637927A5 (enExample)
CS (1) CS226181B2 (enExample)
CY (1) CY1201A (enExample)
DD (1) DD141520A5 (enExample)
DE (1) DE2901181C2 (enExample)
DK (1) DK158346C (enExample)
EG (1) EG14045A (enExample)
ES (2) ES476755A1 (enExample)
FI (1) FI71126C (enExample)
FR (1) FR2415099A1 (enExample)
GB (2) GB2083458B (enExample)
GR (1) GR64431B (enExample)
HK (1) HK12184A (enExample)
HU (1) HU179793B (enExample)
IE (1) IE47798B1 (enExample)
IL (1) IL56411A (enExample)
IN (1) IN150226B (enExample)
IT (1) IT1164655B (enExample)
LU (1) LU80786A1 (enExample)
MC (1) MC1232A1 (enExample)
MX (2) MX5793E (enExample)
NL (1) NL191707C (enExample)
NO (1) NO151320C (enExample)
NZ (1) NZ189378A (enExample)
OA (1) OA06156A (enExample)
PH (2) PH15725A (enExample)
PL (2) PL116532B1 (enExample)
PT (1) PT69068A (enExample)
RO (2) RO80311A (enExample)
SE (2) SE448874B (enExample)
SU (1) SU820659A3 (enExample)
YU (2) YU42172B (enExample)
ZA (1) ZA79219B (enExample)
ZM (1) ZM579A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
NZ199080A (en) * 1980-12-12 1984-07-31 Beecham Group Ltd 2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
KR20060011873A (ko) * 2003-05-16 2006-02-03 화이자 프로덕츠 인코포레이티드 비정형 항정신약과 ｇａｂａ 조절제, 항경련성 약물 또는 벤조다이아제핀의 치료 혼합물
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
JP2007537232A (ja) * 2004-05-11 2007-12-20 ファイザー・プロダクツ・インク 非定型抗精神病薬と５−ｈｔ１ｂ受容体拮抗薬の組合せ
AU2006239900A1 (en) * 2005-04-22 2006-11-02 Wyeth Therapeutic combinations for the treatment or prevention of psychotic disorders
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
CA2727573A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
EP2582665A1 (en) 2010-06-17 2013-04-24 Lupin Limited An improved process for preparation of amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
JP6968899B2 (ja) * 2016-11-28 2021-11-17 エルビー・ファーマシューティカルズ・インコーポレイテッド 向精神薬およびその使用
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
JP7268026B2 (ja) 2017-12-05 2023-05-02 サノビオン ファーマシューティカルズ インク 非ラセミ混合物およびその使用
MX2020005517A (es) 2017-12-05 2020-11-09 Sunovion Pharmaceuticals Inc Formas cristalinas y metodos de produccion de las mismas.
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
US11160758B2 (en) 2019-06-04 2021-11-02 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
USD1047552S1 (en) * 2021-04-23 2024-10-22 Krueger International, Inc. Furniture leg with frame
CN116003304A (zh) * 2023-02-08 2023-04-25 浙江皓华制药有限公司 一种氨磺必利的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (enExample) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (en) * 1975-02-07 1978-07-21 Soc Et Scient Et Ind Substd. N-(1-benzylpyrrolidinyl-2-alkyl)benzamides - used as antiemetics, anti-ulcer agents and CNS active
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
SE412908B (sv) * 1974-12-18 1980-03-24 Synthelabo Forfarande for framstellning av terapeutiskt aktiva 2-metoxibensamider innehallande en pyrrolidin- eller en piperidinrest

Also Published As

Publication number Publication date
DE2901181C2 (de) 1984-07-19
PL118151B1 (en) 1981-09-30
NZ189378A (en) 1983-03-15
ATA39879A (de) 1983-12-15
MX5793E (es) 1984-07-19
DK158346B (da) 1990-05-07
NL7900457A (nl) 1979-07-24
YU42172B (en) 1988-06-30
GB2083458B (en) 1983-03-09
PT69068A (fr) 1979-02-01
SE448874B (sv) 1987-03-23
AR221354A1 (es) 1981-01-30
DE2901181A1 (de) 1979-07-26
PL212899A1 (enExample) 1980-01-14
US4294828A (en) 1981-10-13
DD141520A5 (de) 1980-05-07
NO151320B (no) 1984-12-10
PL116532B1 (en) 1981-06-30
IE790092L (en) 1979-07-20
SU820659A3 (ru) 1981-04-07
GB2083458A (en) 1982-03-24
AU4337379A (en) 1979-07-26
IT1164655B (it) 1987-04-15
FI71126B (fi) 1986-08-14
FR2415099B1 (enExample) 1981-02-20
NL191707C (nl) 1996-04-02
PH15725A (en) 1983-03-18
BG31496A3 (bg) 1982-01-15
YU25483A (en) 1983-10-31
SE460968B (sv) 1989-12-11
IE47798B1 (en) 1984-06-27
NL191707B (nl) 1995-12-01
EG14045A (en) 1983-09-30
GB2012765A (en) 1979-08-01
CH637927A5 (fr) 1983-08-31
DK20979A (da) 1979-07-21
RO76393A (ro) 1981-03-30
YU5079A (en) 1983-06-30
IT7947706A0 (it) 1979-01-18
CS226181B2 (en) 1984-03-19
ES477782A1 (es) 1979-09-16
SE7900380L (sv) 1979-07-21
SE8603773D0 (sv) 1986-09-09
IN150226B (enExample) 1982-08-21
ZM579A1 (en) 1979-12-21
IL56411A0 (en) 1979-03-12
OA06156A (fr) 1981-06-30
ES476755A1 (es) 1979-06-01
YU41278B (en) 1986-12-31
LU80786A1 (fr) 1979-09-07
HK12184A (en) 1984-02-24
NO790180L (no) 1979-07-23
IL56411A (en) 1982-09-30
BE872585A (fr) 1979-06-07
FI71126C (fi) 1986-11-24
DK158346C (da) 1990-10-08
GB2012765B (en) 1982-09-08
AR220574A1 (es) 1980-11-14
JPS54145658A (en) 1979-11-14
MX7623E (es) 1990-03-27
AU528561B2 (en) 1983-05-05
HU179793B (en) 1982-12-28
SE8603773L (sv) 1986-09-09
CA1101430A (en) 1981-05-19
RO80311A (ro) 1982-12-06
FI790182A7 (fi) 1979-07-21
ZA79219B (en) 1980-01-30
BG31497A3 (bg) 1982-01-15
PH22287A (en) 1988-07-22
GR64431B (en) 1980-03-21
CY1201A (en) 1983-12-31
JPS6049192B2 (ja) 1985-10-31
FR2415099A1 (fr) 1979-08-17
US4401822A (en) 1983-08-30
NO151320C (no) 1985-04-17
AT377977B (de) 1985-05-28

Similar Documents

Publication Publication Date Title
MC1232A1 (fr) Nouveaux derives de 4-amino-5-alkylsulfonyl orthoanisamides,leurs procedes de preparation et leur application comme agents psychotropes
FR2487829A2 (fr) Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
IE58325B1 (en) Aminomethyl oxooxazolidinyl benzene Derivatives useful as antibacterial agents
HU179734B (en) Process for producing pharmaceutically effective new n-2 above-bracket-1,2,3,4-tetrahydro-8-quinolyl-bracket closed-sulfonyl-l-arginine-amides
JPS63264442A (ja) リポキシゲナーゼ阻害性化合物
FR2460919A1 (fr) Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique
CA2552565C (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
EP0995436A2 (fr) Ligands aux récepteurs sigma, leur application en thérapeutique
US3843796A (en) Antihypertensive agents
FI94640B (fi) Menetelmä farmaseuttisesti käyttökelpoisen (S)-7-(3-amino-1-pyrrolidinyyli)-1-syklopropyyli-6-fluori-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihapon valmistamiseksi
CA2127066A1 (fr) Derives d'.alpha. amino acides leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0024960A2 (fr) Nouvelles phénoxyamines hétérocycliques substituées, procédé pour leur préparation et leur application comme anesthésiques locaux
EP0262053A2 (fr) Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant
CA1265803A (fr) Amides substitues, leur preparation et les medicaments qui les contiennent
RO104347B1 (en) Production method of amids acids cyclomethylen - 1,2 - dicarboxylic
US4285935A (en) Dehydropeptide compounds, their production and their medical use
EP0078765B1 (fr) Dérivés de p-acylaminophénol à effet thérapeutique, procédé pour leur préparation, et composition à effet thérapeutique contenant lesdits dérivés à titre d'ingrédients pharmacologiquement actifs
EP0047207B1 (fr) N-(1-allyl 2-pyrrolidinyl méthyl) 2-méthoxy 4-amino 5-méthylsulfamoyl benzamide, son procédé de préparation et son application comme médicament
EP0061406B1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
JPH0341459B2 (enExample)
MC1288A1 (fr) N-(1-methyl 2-pyrrolidinyl methyl)2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives,leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
FR2570699A1 (fr) Nouveau procede de preparation de derives du 4h-1,2,4-triazole, nouveaux triazoles ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2522663A1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
FR2584722A1 (fr) Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
FR2509298A1 (fr) Nouveaux derives de cystine et leurs sels utiles comme medicaments et procede de leur preparation

Legal Events

Date Code Title Description
YP Annual fee paid